Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p>Results of a large-scale study indicated that 70% of women with a common type of breast cancer do not experience a benefit from chemotherapy. Data suggest that for women with hormone receptor-positive, human epidermal growth factor receptor 2-negative, axillary lymph node-negative breast cancer, post-surgery combination chemotherapy and hormone therapy treatment provides no additional benefit over hormone therapy on its own.</p>

Research Examines Options for Those With Early-stage Breast Cancer